← FDA MEDWATCH
FDA (US) · MEDWATCH SAFETY ALERTSeptember 21, 2026
Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter
What this record is not
Item details are published by the U.S. FDA on fda.gov; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA. The authoritative notice is on fda.gov.
Item type
MedWatch Safety Alert
Published
September 21, 2026
Source
U.S. FDA (MedWatch / press releases)
What this signals · SPEQ interpretation
SPEQ reads this FDA MedWatch item’s stated subject as touching contamination control. That is a keyword reading of the published subject, not an official classification — the requirements and playbooks below are where a team would look to prevent or close it.
Requirements behind it
Decode the practice
DisciplinesGMP
READ THE FULL FDA NOTICE
The complete FDA notice — the affected products, the action required, and any recall detail — is published on fda.gov. SPEQ surfaces and indexes it for reference; the authoritative notice lives on fda.gov.
View on fda.gov →